IonOpticks

IonOpticks is an Australian biotechnology company based in Melbourne, established in 2017. The company specializes in developing and manufacturing advanced chromatography columns for liquid chromatography-mass spectrometry (LC-MS), focusing on proteomics research. IonOpticks has quickly become a global leader in high-performance nanoflow chromatography solutions that improve the sensitivity, accuracy, and throughput of mass spectrometry analyses. The flagship product line, the Aurora Series®, including the Generation 4 Aurora Series®, is designed to enhance mass spectrometry sensitivity and throughput. These chromatography columns are utilized in various applications, such as advanced proteomics and phosphoproteomics, allowing scientists and clinicians to achieve deeper insights in their analyses. IonOpticks also offers application notes and technical support to optimize the performance of their products with different mass spectrometry platforms. The company serves a diverse global research community, including pharmaceutical companies, academic institutions, and industry laboratories. IonOpticks is committed to innovation and quality, with a dedicated research and development team focused on expanding their product offerings and maintaining high standards in chromatography and proteomics.

Research Collingwood, Australia ~31 employees

Work at IonOpticks in HR or recruiting? Claim this page

Employees
31
+6.9% in the 3 months to Jun 2025
12-month attrition
9.1%
Tech: 40%
H1B sponsor
NA

Headcount trend

IonOpticks went from 19 employees in Jul 2023 to 31 in Jun 2025. Jan to Jun 2025: 7 people joined, 0 left.

Headcount data through Jun 2025

Org structure

Headcount by department

Other19
Operations6
Sales2
Finance1
Marketing1
Engineering1
Product1

IonOpticks FAQ

How many employees does IonOpticks have?

IonOpticks has about 31 employees, up 6.9% over the 3 months to Jun 2025.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.